Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial.

Autor: Sylvie, Chevret1 (AUTHOR), Lila, Bouadma2,3 (AUTHOR), Claire, Dupuis3,4 (AUTHOR), Charles, Burdet3,5 (AUTHOR), Jean-François, Timsit2,3 (AUTHOR) Jean-francois.timsit@bch.aphp.fr, the COVIDICUS RCT group (AUTHOR), Beldjoudi, Naima (AUTHOR), Chevret, Sylvie (AUTHOR), Burdet, Charles (AUTHOR), Alloux, Céline (AUTHOR), Amerali, Fadila (AUTHOR), Andriss, Béatrice (AUTHOR), Baghli, Kamyl (AUTHOR), Brocvielle, Hélène (AUTHOR), Capelle, Florence (AUTHOR), Chibane, Ines (AUTHOR), Dalibey, Sarra (AUTHOR), Ettalhaoui, Nadia (AUTHOR), Lamri, Sabrine (AUTHOR), Maurer, Yohan (AUTHOR)
Zdroj: Annals of Intensive Care. 8/27/2023, Vol. 13 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje